COVID Updates and all the latest additions to the IHIF COVID-19 Toolkit

Lilly Antibody Therapies Given Emergency Authorization
The U.S. Food and Drug Administration has granted an Emergency Use Authorization for two COVID-19 antibody therapies from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The company says the combination of bamlanivimab and estesevimab can be used for the treatment of mild-to-moderate COVID-19 in patients 12 years of age and older who are at high risk for progressing to severe cases. Read More (Source: Inside Indiana Business)
AdvaMed has updated its VentConnect platform, transforming it into the Med Device Network, which supports the manufacturing and delivery of the 12 critical medical supplies identified in President Joe Biden's National COVID Plan.
Full Story: Medical Design & Outsourcing (2/11)  
Critical Infrastructure Workforce Vaccination Survey
The State of Indiana is prepared to deliver and facilitate the administration of the COVID-19 vaccine as soon as supplies become available. Frontline healthcare workers, long-term care centers and high-risk individuals will be the top priority for initial vaccine deliveries. This tool will help inform the Department of Health as to the need, urgency and capabilities to deliver the vaccine to critical infrastructure/essential employees as quickly as supplies become available. Please complete this survey as quickly as possible to help in those planning efforts.
Hoosier Pharma Company Lands Grant to Fight COVID
The National Science Foundation has awarded a $256,000 grant to a West Lafayette-based startup to help in the fight against COVID-19. Akanocure Pharmaceuticals Inc. says it will use the funding to further study and develop a drug to treat severe cases of the disease, and potentially stop future outbreaks that involve other viruses. Read More (Source: Inside Indiana Business)
With the possibility of COVID-19 vaccines becoming available soon, get the facts on vaccine development. Learn more about the scientific rigor that goes into developing a vaccine, and how the vaccine process is safe and effective.
Member News
Amplified Sciences Winner of Ocean Insight Grant Earning the $10,000 Merit Silver Award

Amplified Sciences, Inc., a diagnostic startup company focused on detecting and pre-empting the risks of debilitating diseases announces that they have earned the Merit Award from Ocean Insight, an applied spectral knowledge company focusing on life sciences and environmental safety applications.  
Read More (Source: Amplified Sciences)
FAST BioMedical Device Achieves Independent Validation by ARDL

FAST BioMedical a privately held late clinical-stage medical technology company, today announces its proprietary device that quantifies volume status and kidney function has been independently validated by a top clinical lab, ARDL. (The Advanced Research and Diagnostics Laboratory).

FAST BioMedical notes ARDL at the University of Minnesota evaluated FAST’s device and found the device performs with accuracy, precision reproducibility, and more. This instrument validation is modeled after Clinical and Laboratory Standards Institute’s guidance used to validate performance of approved clinical assays and instruments and ensures the ability to measure the marker concentrations in human specimens.
Read More (Source: FAST Biomedical)
Toralgen Closes $8.3 Million Seed Funding Round

Toralgen, an Indiana-based biotechnology company has announced the successful completion of its second seed funding round, raising a total of $8.3 million. The preclinical stage company will use the funds to further development of their novel nanoparticle drug delivery platform and advance industry partnerships. Participants in the round include Elevate Ventures, Solyco Advisors, and VisionTech Angels well as investors and strategic partners with deep domain expertise. 
Read More (Source: Toralgen)
Biotech Startup Secures $5.5M Funding Round
A West Lafayette-based biotechnology startup has closed on a $5.5 million Series A round of funding. Novosteo Inc., which is developing compounds to treat bone fractures and other bone diseases, has also named Bill Boyle as its new president and chief executive officer. Read More (Source: Inside Indiana Business)
Assembly Biosciences and Door Pharmaceuticals sign collaboration and option agreement
Assembly Biosciences Inc. (Nasdaq: ASMB) and Door Pharmaceuticals LLC have announced that the companies have signed an exclusive, two-year collaboration and option agreement focused on the development of a novel class of hepatitis B virus core protein modulators.
Read More (Source: IU Communications)
Lilly Invests $30M in Health Venture Fund
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has made a $30 million limited partner investment in a newly-formed venture fund. The company says Unseen Capital Health Fund LP seeks to identify, fund and support "underrepresented founders of early-stage healthcare companies and those building solutions for marginalized communities." 
Read More (Source: Inside Indiana Business)
WATCH: Location Key for Indy Life Sciences Plant
The USA general manager for New Jersey-based Advanced Accelerator Applications says the company chose Indianapolis for its planned $72 million manufacturing facility because of the unique nature of the drug it will produce. Mike Rossi says the radioligand therapies used to treat cancer have a very short shelf life, which is why the company needed a more centralized location. "This location, close to the Indianapolis International Airport and the major ground transportation hubs around the facility, ensures that our medicines can be manufactured, packaged, transported and administered to patients anywhere in North America within 72 hours." Read More (Source: Inside Indiana Business)
Congratulations to BSA LifeStructures ranked #12 on Building Design & Construction's rankings of the nation's largest science and technology (S+T) facilities sector architecture, engineering, and construction firms.

Welcome New IHIF Members!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
Gain the insights you deserve to get the answers you need

Answering the right questions on time and with high-quality data is the key to achieving your objectives. At Inotiv, clinical decision support is our focus: We deliver the comprehensive and integrated range of right-size toxicology services, analysis, bioanalysis, and DMPK and consulting solutions essential to your success.

In choosing a laboratory partner, Expect more: more attention, more insight, and a superlative experience. You’ve worked hard to get this far, and you deserve a provider aligned to your needs and goals.

Through scientific leadership and ongoing investments, Inotiv delivers a comprehensive range of nonclinical and analytical services that will exceed your expectations. Benefit from our long and impeccable regulatory history, world-class team of scientists, and track record of providing attentive, decisive service.
IHIF's Policy Corner
What We're Following at Home and on the Hill

IHIF Actions

  • Sent letter of support for SB62 to Indiana Senate Health and Provider Services Committee
President Joe Biden selected former FDA Commissioner David Kessler as chief science officer on his COVID-19 vaccine development team, replacing Operation Warp Speed chief science advisor Moncef Slaoui. Geneticist Eric Lander will be Biden's science adviser and director of the Office of Science and Technology Policy if confirmed by Congress; and Francis Collins will stay on as NIH director.
Full Story: The Associated Press (1/15),  
A last-ditch effort to strip Medicare Part D protections
Before we move forward, we must take a step back to address a sweeping policy change made by former President Donald Trump on Inauguration Eve to the Medicare “Part D” drug benefit—one of several major policy changes in the final hours of his administration.
The outgoing Trump administration announced a new policy that would allow insurance plans to cover fewer “protected” drugs in their formularies beginning next year.

Generally, Part D sponsors have flexibility in which drugs they cover in commonly prescribed categories and classes. 

But they’ve been required to cover all FDA-approved drugs in six “protected classes”: antidepressants, antipsychotics, anticonvulsants, immunosuppressants for treatment of transplant rejection, antiretrovirals (for treatment of HIV), and antineoplastics.

Now: “Proposed changes could result in seniors losing access to treatments they rely on, including antidepressants, antipsychotics, anticonvulsants, immunosuppressants, and antineoplastics,” explained BIO President and CEO Dr. Michelle McMurry-Heath. (HIV treatments remain protected.) 

“Previous attempts to modify Medicare’s ‘protected’ drug classes have been met with fierce opposition by patients, stakeholders, and members of Congress—and for good reason,” she said. “Removing these protections will undoubtedly have a crushing effect on patients with mental health issues, cancer, transplants, and other life-threatening conditions."
(Source: Good Day BIO 1/21)
Upcoming Events
APRIL 30, 2021
Where Innovation Meets Capital
March 16-18, 2021
The Indiana Health Industry Forum is pleased to announce its sponsorship and invite you to join us at Venture Summit Virtual Connect West, featuring a dedicated Lifesciences / Healthcare Track
Special offer: 20% off Early Bird Rates (Use discount code “IHIFVIP")
* Call for Top Innovators Details below
Come meet, interact and network online with more than 1,500 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage companies at the prestigious Venture Summit Virtual Connect West being held virtually on March 16th-18th 2021, featuring a dedicated Lifesciences / Healthcare track.

Whether you’re a Biotech startup seeking capital and exposure, or an investor seeking new deals, the Lifesciences / Healthcare track at Venture Summit Virtual Connect West presented by youngStartup Ventures - is the event of the year you won't want to miss.

A highly productive venture conference, Venture Summit Virtual Connect West will bring together over 1,500 VCs, Corporate VCs, Angel Investors, ‎Industry executives and founders of venture backed, emerging and early stage companies; will feature ‎One-on-One networking (online), more than 150 VCs as speakers/ judges; Venture panels, startup workshops, presentations by more than 100 Top Innovators and ‎Keynotes.

Special Offer:
Indiana Health Industry Forum has made special arrangement for our network to receive a unique discount of an additional 20% off the existing “early bird" savings. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

Register Today & Save Click here (Use promo code "IHIFVIP)

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.

Get Noticed > Get Funded > Grow Faster
A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.
Apply to Present / Nominate a company:
For more information or to be considered for one of the Top Innovator slots click here.
Seed Pitchfest:
If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000click here to apply for the Seed stage track.
We look forward to seeing you there. 
With the industry preparing for increased activity around partnering events in 2021, due in part to the virtual and hybrid nature of hosted meetings, it will be critical to establish a strategic roadmap for engagement that accelerates the effectiveness of your business development efforts. 

Elevate your presence at BIO’s established portfolio of independent investor and partnering events and attract the attention of hundreds of business development leaders, licensing professionals and investors from across the globe. 

*Please note, IHIF Membership does not qualify for the BIO Member discounts.
BIO Digital
June 10-11, 14-18, 2021

Ready to expand your company's visibility and partnership opportunities beyond borders in 2021? Join the Innovation Stage, BIO Digital's new interactive forum showcasing the hottest companies in biotech!
How does it work? Fast-paced presentations and networking allow you to showcase your company, biotech region, or technology to a global audience of prospective partners ahead of BIO Digital Week. Early access programming June 10-11 includes the new can't-miss Global Marketplace, allowing state and international delegations to tell their stories, plus other exciting tracks that will help your company rise to new heights!
With several options to participate, explore the new Innovation Stage and how your company or organization can get involved.

Announcing the 2020 - 2021 IN Life Sciences Collaboration Conference Series!

Since 2006, CBLS has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.
This year's series will begin virtually, building upon great subjects and quality presenters just as in previous years. The November format is modified for a half-day schedule over a two day span. We are excited to leverage the highly ranked Kelley School of Business' online learning resources for educational and networking opportunities for the series!
Advances in Behavioral/Mental Health Treatments
February 19, 2021
Lessons Learned from the Pandemic
April 30, 2021
Format TBD
From the Purdue University Weldon School of Biomedical Engineering
Navigating the Regulatory Pathway for Medical Devices: A Conversation With the FDA, Clinicians, Researchers, and Industry Experts
Friday February 26, 2021
10am - 3pm EST
Virtual Conference
Dr. Jeffrey E. Shuren, MD, JD
Director of the Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration (FDA)
In his leadership of CDRH, Dr. Shuren is responsible for the review of FDA-regulated medical devices and diagnostics in the United States and for helping to facilitate medical device innovation.

  • Presentations and panel discussion with FDA experts and industry leaders
  • Breakout conversations with key leaders at the FDA, clinicians, university researchers and industry experts on the following topics:
  • Pediatric Medical Devices
  • Diagnostic and Disease Detection
  • Digital Health and Wearable Devices
Invasive and Implantable Devices

Announcing the Genes in Space 2021 US contest
Genes in Space is a free experimental design competition where students propose research projects to be carried out in space. We are excited to announce that the 2021 competition will begin accepting submissions on January 19th. 
Industry News
Columbia City Medical Company Partners With Conformis
Maryland-based Conformis Inc. (Nasdaq: CFMS) and SITES Medical in Columbia City have entered into a non-exclusive development and supply agreement. The companies say they will work together to incorporate SITES Medical’s OsteoSync Ti Technology into future Conformis’ knee replacement products. Read More (Source: Inside Indiana Business)
Hoosier Companies Partner on Medical Device Component
Two Indiana companies are teaming up on the development of a metal technology to be used in medical devices. Warsaw-based Nextremity Solutions Inc. says it has entered into an exclusive supply agreement with Fort Wayne Metals, which will provide access to a specialty magnesium-based alloy that will be used in orthopedic implants. Read More (Source: Inside Indiana Business)
Partnership Created to Accelerate Healthcare Innovation
Regenstrief Institute in Indianapolis is partnering with an Indy-based venture studio to expand the reach of healthcare-related innovations. The institute says through the partnership, Boomerang Ventures will also benefit from the expertise of its research scientists. Read More (Source: Inside Indiana Business)
Zimmer Biomet Announces Spine, Dental Business Spin-Off
Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has announced plans to spin off its spine and dental businesses to form a new and independent, publicly-traded company. The medical device manufacturer says NewCo is expected to achieve faster growth and deliver greater value for stakeholders. Read More (Source: Inside Indiana Business)
Fort Wayne Company Secures FDA Clearance
Fort Wayne-based BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly Great Toe Implant. With the clearance, the orthopedic manufacturer says the technology is available for the first time in the U.S. Read More (Source: Inside Indiana Business)
Life Sciences Facility Plans Expansion in Charlestown
New Jersey-based J. Knipper and Company Inc. says it plans to invest $17.4 million to expand its distribution center located in the River Ridge Commerce Center and grow its workforce by 38 people. Knipper provides supply chain services to the U.S. pharmaceutical industry. Read More (Source: Inside Indiana Business)
BIO Business Solutions - Special Discounts for IHIF Members
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
Featured Program
About is an online marketplace for outsourced scientific services and products, offering researchers access to a platform with thousands of pre-qualified suppliers providing custom research services.
IHIF Member Benefits 

  • Savings realized by receiving competitive price quotes from multiple suppliers
  • Discounted Platform and Yearly Fees
  • Access to the world's largest commercial CRO network - 2,600+ prequalified, registered suppliers
  • Vendor consolidation - all contracting and billing managed by
  • Choose from over 3,800 research areas, including:
  • Human Biological Samples
  • Next Generation Sequencing (NGS)
  • Custom Antibodies

About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!